The research team, led by Andriy Anishkin, Sangita Kachhap, and Sree V. Chintapalli across institutions including the University of Maryland and the Arkansas Children’s Nutrition Center, focused on two closely related metabolic cargo molecules. The first is palmitate, a sixteen-carbon saturated fatty acid that circulates abundantly in the bloodstream. The second is palmitoylcarnitine, the same fatty acyl chain but shuttled on a carnitine headgroup, the form in which long-chain fatty acids cross into mitochondria for beta-oxidation. Earlier work from the same group had shown that oxygenated myoglobin binds both molecules in a hydrophobic pocket near the heme, and that acylcarnitines actually grip the protein more tightly than free fatty acids do. What remained unknown was whether this bound cargo changes the protein’s behavior once it reaches the mitochondrial surface.

To answer that question, the team turned to molecular dynamics simulations, a technique that models every atom of a protein and membrane as they jiggle, rotate, and interact according to the laws of physics. They built two physiologically distinct models of the outer mitochondrial membrane. The first, an average-composition membrane, reflected the typical mixture of phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, and other headgroups found across the mitochondrial surface. The second, a contact-site membrane, was enriched in cardiolipin, a doubly charged phospholipid that clusters at specialized regions where the outer and inner mitochondrial membranes come into close apposition. Cardiolipin is best known as a signature lipid of the inner membrane, but its presence at contact sites makes those patches distinctly more negatively charged than the rest of the surface.

Into each membrane environment the researchers placed oxygenated myoglobin carrying either palmitate or palmitoylcarnitine, testing six different starting orientations of the protein so that no single docking pose would dominate the results. The simulation protocol unfolded in three stages. First, a weak steering force of roughly eleven piconewtons nudged each protein toward the membrane over forty nanoseconds, allowing thermal motion to rotate and reposition the complex so the final contact configuration depended little on the initial orientation. Then the external force was removed entirely, and each system relaxed for another forty nanoseconds to see whether the newly formed contacts would hold. Finally, a steered molecular dynamics phase pulled the protein away from the membrane at a constant velocity, recording the force required to break the association.

The results were striking in two ways. First, both lipid-bound forms of oxygenated myoglobin showed a clear preference for the cardiolipin-rich contact-site membrane over the average-composition membrane. The stability of the association, measured by how many protein-membrane atomic contacts survived the unrestrained relaxation phase, was 2.3-fold higher at the contact site for palmitate-bound myoglobin and 2.7-fold higher for palmitoylcarnitine-bound myoglobin. This mirrors the team’s earlier finding that unliganded oxygenated myoglobin also favors contact-site regions, and it suggests that cardiolipin’s negative charge acts as a general electrostatic beacon for the oxygen-carrying protein.

But the second result is what makes the new study stand out: the identity of the bound lipid changed everything about how the protein behaved at the membrane. Palmitate-bound myoglobin was ten to twenty percent more stable overall than its palmitoylcarnitine-bound counterpart, and when the researchers pulled the complexes off the membrane, palmitate-bound myoglobin required roughly twice the detachment force. At the contact-site membrane, the average detachment forces were 74.7 piconewtons for the palmitate complex versus 40.8 piconewtons for the palmitoylcarnitine complex. Lipid-specific contact analysis revealed why the two complexes behaved so differently: palmitate-bound myoglobin was strongly stabilized by cardiolipin, while palmitoylcarnitine-bound myoglobin leaned instead on phosphatidylethanolamine and phosphatidylinositol, with a smaller contribution from cardiolipin.

What makes this divergence remarkable is that the two cargo molecules share the identical sixteen-carbon palmitoyl chain. The only meaningful difference is the polar headgroup: palmitate carries a carboxylate, while palmitoylcarnitine carries the bulkier carnitine moiety. Yet that single chemical distinction was enough to rewire the entire network of protein-lipid contacts. Residue-level mapping showed that lysine-rich regions of the protein, particularly around helix F and the loop connecting helices C and D, dominated the membrane interactions, but the relative contributions of individual residues shifted depending on which lipid was bound. The authors emphasize that membrane stabilization was distributed across multiple residues and lipid species rather than concentrated at a single interaction site, pointing to a multicomponent, orientation-dependent mode of association.

The orientation result may prove to be the most consequential. In several palmitoylcarnitine-bound configurations, the heme crevice, the structural gateway through which oxygen enters and exits myoglobin, faced toward the membrane, whereas the more firmly anchored palmitate complex tended to adopt different membrane-facing poses. The researchers are careful to note that they did not directly simulate or measure oxygen release, so these orientation differences cannot yet be interpreted as evidence of faster or slower oxygen delivery. Still, the structural implications are tantalizing, because recent experimental work has shown that membrane contact itself perturbs the heme environment. A 2026 study in the Journal of the American Chemical Society reported that association with model liposomes roughly doubled the rate of oxygen dissociation from myoglobin, and complementary resonance Raman experiments showed that membrane-mimicking surfaces weaken the iron-oxygen bond. If the membrane is not just a docking site but an active participant in unloading oxygen, then the orientation of the heme crevice relative to the membrane surface becomes a potentially critical variable, and one that the bound metabolite appears to control.

The physiological context gives the finding real weight. Long-chain acylcarnitines accumulate in the blood and tissue when mitochondrial fatty acid oxidation falls behind substrate supply, a situation that arises during myocardial ischemia and in various metabolic disorders. Endurance exercise, fasting, and dietary fat intake all shift the balance between free fatty acids and acylcarnitine intermediates in muscle. The new simulations suggest that these metabolic fluctuations could change not just how much lipid-bound myoglobin sits at the mitochondrial surface, but in what configuration, potentially coupling oxygen delivery to the cell’s current fuel mix. The authors also point toward broader nutrient-sensing pathways such as mTORC1, which governs lipid metabolism and mitochondrial function, as a possible upstream regulator of the fatty acid and acylcarnitine pools that myoglobin encounters.

The study has clear limitations that the authors acknowledge candidly. Their membrane models contained only phospholipids, omitting the integral and peripheral proteins that crowd the real outer mitochondrial membrane, and the detachment forces measured under nonequilibrium pulling conditions cannot be read as equilibrium binding affinities. Oxygen release and lipid transfer were not directly measured, and the sampling, though broadened by six starting orientations per condition, represents a subset of the full conformational landscape. Even so, the central message is hard to escape: myoglobin’s metabolic cargo is not a passenger but a steering wheel. The same protein, carrying the same acyl chain, grips the mitochondrial surface with different strength, different lipid preferences, and different geometry depending on whether that chain arrives as a free fatty acid or a carnitine ester. Future experiments that directly measure oxygen release kinetics and lipid transfer from these complexes will determine whether this structural plasticity translates into a genuine regulatory mechanism, one that could tie the rhythm of cellular respiration to the shifting tides of fat metabolism in working muscle.

Subject of Research: How fatty acid and acylcarnitine binding modulates oxygenated myoglobin's interaction with the outer mitochondrial membrane

Article Title: Long-chain fatty acid- and acylcarnitine-bound oxygenated myoglobin interactions with outer mitochondrial membrane

Article References: Long-chain fatty acid- and acylcarnitine-bound oxygenated myoglobin interactions with outer mitochondrial membrane. (n.d.). https://doi.org/10.3389/fbinf.2026.1986755

Image Credits: AI Generated

DOI: 10.3389/fbinf.2026.1986755

Keywords: myoglobin, mitochondria, molecular dynamics, palmitate, palmitoylcarnitine, cardiolipin, outer mitochondrial membrane, oxygen transport, fatty acid metabolism, acylcarnitines, heme, simulations

The importance of beta-barrel proteins to mitochondrial biology is difficult to overstate. TOM40 forms the primary channel through which nearly all mitochondrial proteins enter the organelle, while the VDACs regulate the flow of metabolites such as ATP and ions across the outer membrane. SAM50, the central pore-forming subunit of the SAM complex, belongs to the Omp85 family of bacterial and organellar proteins, and it carries a distinctive structural feature called a lateral gate. This gate is a region of the barrel that can open sideways, allowing a nascent beta-barrel substrate to partially release from the SAM50 lumen and begin folding into its own barrel within the membrane. Decades of work on bacterial and mitochondrial assembly machineries have established that barrel folding proceeds hand in hand with conformational changes at these lateral gates, making the gate a dynamic control point rather than a static seam.

In fungi, where the SAM complex consists of Sam50 plus the peripheral subunits Sam35 and Sam37, high-resolution structural studies have established what researchers call a beta-barrel-switching model. In this model, a second beta-barrel protein binds dynamically at a site immediately adjacent to the lateral gate of Sam50, effectively handing off the growing substrate from one barrel to another as folding proceeds. The fungal structures showed this switching site occupied by barrel proteins caught in the act of assembly, providing a snapshot of the folding pathway in progress. But a critical question has lingered: do mammalian SAM complexes, which use entirely different peripheral subunits, work the same way? In humans, the proteins METAXIN1 and METAXIN2 replace Sam37 and Sam35 respectively, and whether the human machine employs an equivalent switching mechanism had remained unresolved.

The new study answers that question with striking structural detail. The research team, including co-first authors Ling Yan, Zeyuan Guan and Qiang Wang, determined cryo-EM structures of two distinct forms of the human SAM complex. The first is a monomeric complex containing a single SAM50 molecule paired with one METAXIN2, forming a SAM50-METAXIN2 core. The second is a dimeric complex containing two SAM50 molecules, again with one METAXIN2 associated. The atomic coordinates and cryo-EM maps for both structures have been deposited in public databases, with the monomeric complex archived under PDB code 25WG and EMDB entry EMD-80424, and the dimeric complex under PDB 25WF and EMD-80423, allowing researchers worldwide to examine the molecular details directly.

The dimeric structure is the showstopper. Rather than simply sitting side by side, the two SAM50 barrels adopt what the authors describe as an interlocked conformation: each SAM50 molecule extends beta-strands into the barrel lumen of its partner. This molecular intertwining means that one SAM50 barrel physically occupies the beta-barrel-switching site adjacent to the lateral gate of the other SAM50. In other words, the dimer captures the human SAM complex in a configuration that directly mirrors the fungal beta-barrel-switching model, but with the remarkable twist that the second barrel at the switching site is another copy of SAM50 itself. This suggests that in human mitochondria, a second SAM50 molecule may serve as a placeholder or scaffold at the switching site, potentially priming the machine for substrate engagement or reflecting a regulatory state in the assembly cycle.

To test whether this dimeric arrangement is functionally meaningful rather than a crystallographic artifact of sample preparation, the team turned to biochemical and cell-based approaches. Crosslinking experiments, which chemically freeze transient protein-protein contacts so they can be detected, provided independent evidence for the close apposition of the two SAM50 molecules in living systems. More tellingly, the researchers employed fluorescence lifetime imaging microscopy combined with Foerster resonance energy transfer, a technique known as FLIM-FRET that reports on nanometer-scale distances between fluorescently labeled proteins inside cells. These analyses revealed that METAXIN1, the mammalian counterpart of fungal Sam37, alters the conformation of SAM50 and changes the relative arrangement of the two SAM50 molecules in the dimeric complex.

This METAXIN1-dependent remodeling is a key finding because it demonstrates that the dimeric SAM assembly is not a rigid, static structure but a dynamic platform whose geometry is actively tuned by peripheral subunits. In the fungal system, Sam37 plays roles in substrate release from the SAM complex, and the implication is that METAXIN1 may perform an analogous regulatory function in human cells, repositioning the SAM50 barrels to facilitate the progression of substrate folding and release. The structural and functional data together suggest a working model in which the human SAM complex cycles between monomeric and dimeric states, with METAXIN1 and METAXIN2 orchestrating conformational transitions that drive beta-barrel substrates through the folding pathway.

The evolutionary dimension of this work is equally compelling. The fact that the beta-barrel-switching principle is conserved from fungi to humans, despite the complete replacement of the peripheral subunits Sam35 and Sam37 with METAXIN2 and METAXIN1, indicates that the core mechanism of barrel assembly is ancient and tightly constrained. The Omp85 family spans bacteria, chloroplasts and mitochondria, and lateral-gate dynamics have been documented across all these systems. What the new structures add is the demonstration that the switching site itself, the physical location where a second barrel docks next to the gate, is a conserved feature of the mitochondrial machinery, even as the molecular players that regulate it have been swapped out during evolution. This kind of architectural conservation with component turnover is a recurring theme in mitochondrial biology and underscores the deep common ancestry of the organelle’s protein import systems.

Why should this matter beyond structural biology? Defects in mitochondrial protein import and outer membrane assembly are increasingly linked to human disease, and the VDACs and TOM40 in particular have been implicated in neurodegeneration, cancer metabolism and mitochondrial dysfunction more broadly. By defining the conformational states of the human SAM complex and identifying METAXIN1 as a remodeling factor, the study establishes a framework that other researchers can use to probe how barrel assembly goes wrong in disease contexts, and potentially how it could be modulated. The structures also provide concrete molecular targets for future studies of METAXIN function, which until now have been largely mysterious in mechanistic terms.

The work also showcases the power of modern cryo-electron microscopy to resolve small, dynamic membrane protein assemblies that were once considered beyond reach. Capturing both the monomeric and interlocked dimeric states of the human SAM complex, complete with the beta-strand exchange between barrels, required both technical skill in sample preparation and data collection, acknowledged by the authors to the cryo-EM facilities at the University of Science and Technology of China and Huazhong Agricultural University, and sophisticated computational reconstruction. As cryo-EM continues to push toward smaller and more heterogeneous complexes, studies like this one are filling in the remaining gaps in our understanding of how cells build their most essential molecular machines. For the mitochondrial outer membrane, the picture is now coming into focus: a conserved barrel-switching engine, remodeled by mammalian-specific regulators, assembling the channels that keep cellular power plants running.

Subject of Research: Cryo-EM structures of the human mitochondrial SAM complex involved in beta-barrel protein assembly

Article Title: Cryo-EM structures of monomeric and dimeric human SAM complexes

Article References: Yan, L., Guan, Z., Wang, Q., Wu, Y., Qi, L., Huang, C., Zhang, J., Hong, S., Zhuang, J., Huang, R., Zhang, L., Duan, R., Liu, Y., Liu, Z., & Yin, P. (2026). Cryo-EM structures of monomeric and dimeric human SAM complexes. Cell Research. https://doi.org/10.1038/s41422-026-01305-w

Image Credits: AI Generated

DOI: 10.1038/s41422-026-01305-w

Keywords: cryo-EM, mitochondria, SAM complex, SAM50, beta-barrel proteins, METAXIN1, METAXIN2, protein folding, outer mitochondrial membrane, TOM40, VDAC, structural biology